Female Health Stock Current Liabilities
| FMW Stock | EUR 0.62 0.03 5.08% |
FEMALE HEALTH fundamentals help investors to digest information that contributes to FEMALE HEALTH's financial success or failures. It also enables traders to predict the movement of FEMALE Stock. The fundamental analysis module provides a way to measure FEMALE HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to FEMALE HEALTH stock.
FEMALE |
FEMALE HEALTH Company Current Liabilities Analysis
FEMALE HEALTH's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, FEMALE HEALTH has a Current Liabilities of 0.0. This indicator is about the same for the Other average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
FEMALE Fundamentals
| Current Valuation | 350.37 M | |||
| Price To Book | 5.40 X | |||
| Price To Sales | 11.03 X | |||
| Revenue | 39.35 M | |||
| EBITDA | (78.96 M) | |||
| Net Income | (83.78 M) | |||
| Total Debt | 9.66 M | |||
| Cash Flow From Operations | (47.51 M) | |||
| Market Capitalization | 442.9 M | |||
| Total Asset | 136.13 M | |||
| Z Score | 27.0 | |||
| Net Asset | 136.13 M |
About FEMALE HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FEMALE HEALTH's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FEMALE HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FEMALE HEALTH based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in FEMALE Stock
FEMALE HEALTH financial ratios help investors to determine whether FEMALE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FEMALE with respect to the benefits of owning FEMALE HEALTH security.